Rimonabant (Acomplia, Zimulti) was created by a French Pharmaceutical Company Sanofi-Aventis or Sanofi-Synthelabo. This medication appeared to be a new method to overcome a problem of weight loss as it is used specially to treat obesity and perhaps some other ailments. Merck reiterated on January. 19th that it plans to file for FDA approval of diet drug Acomplia (rimonabant) Taranabant in 2008 even though some adverse psychiatric side-effects have been observed similar to those found with Sanofi diet drug Acomplia (rimonabant)
the European Commission granted a marketing authorisation valid throughout the European Union for the medicinal product Acomplia (rimonabant), indicated as an adjunct to diet and exercise for the treatment of obese patients (BMI = 30 kg/m2), or...
No comments:
Post a Comment